Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
26 01 2023
Historique:
received: 09 12 2022
revised: 21 01 2023
accepted: 24 01 2023
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 3 3 2023
Statut: epublish

Résumé

The Marburg and Ebola filoviruses cause a severe, often fatal, disease in humans and nonhuman primates but have only subclinical effects in bats, including Egyptian rousettes, which are a natural reservoir of Marburg virus. A fundamental question is why these viruses are highly pathogenic in humans but fail to cause disease in bats. To address this question, we infected one cohort of Egyptian rousette bats with Marburg virus and another cohort with Ebola virus and harvested multiple tissues for mRNA expression analysis. While virus transcripts were found primarily in the liver, principal component analysis (PCA) revealed coordinated changes across multiple tissues. Gene signatures in kidney and liver pointed at induction of vasodilation, reduction in coagulation, and changes in the regulation of iron metabolism. Signatures of immune response detected in spleen and liver indicated a robust anti-inflammatory state signified by macrophages in the M2 state and an active T cell response. The evolutionary divergence between bats and humans of many responsive genes might provide a framework for understanding the differing outcomes upon infection by filoviruses. In this study, we outline multiple interconnected pathways that respond to infection by MARV and EBOV, providing insights into the complexity of the mechanisms that enable bats to resist the disease caused by filoviral infections. The results have the potential to aid in the development of new strategies to effectively mitigate and treat the disease caused by these viruses in humans.

Identifiants

pubmed: 36851566
pii: v15020350
doi: 10.3390/v15020350
pmc: PMC9958679
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI136916
Pays : United States

Références

Prz Gastroenterol. 2014;9(4):208-13
pubmed: 25276251
Hypertens Res. 2016 Jul;39(7):492-500
pubmed: 26888118
Virol J. 2012 Oct 13;9:236
pubmed: 23062147
Vasc Health Risk Manag. 2010 Apr 15;6:199-205
pubmed: 20407627
J Infect Dis. 2019 May 5;219(11):1716-1721
pubmed: 30590775
J Wildl Dis. 2015 Jan;51(1):113-24
pubmed: 25375951
Cell Host Microbe. 2018 Sep 12;24(3):405-416.e3
pubmed: 30173956
Int J Hematol. 2008 Jul;88(1):7-15
pubmed: 18594779
JCI Insight. 2019 Jan 10;4(1):
pubmed: 30626757
PLoS One. 2012;7(9):e45479
pubmed: 23029039
Blood. 2010 Jun 10;115(23):4742-9
pubmed: 20351312
Nat Commun. 2015 Dec 11;6:10112
pubmed: 26656251
PLoS Negl Trop Dis. 2010 Aug 24;4(8):e802
pubmed: 20808767
J Infect Dis. 2015 Feb 15;211(4):661-2
pubmed: 25160984
Sci Rep. 2016 Oct 07;6:34589
pubmed: 27713552
J Biol Chem. 2017 Aug 4;292(31):12735-12743
pubmed: 28615441
Cell Rep. 2020 Aug 18;32(7):108028
pubmed: 32814037
Front Immunol. 2018 Aug 10;9:1803
pubmed: 30147687
Blood. 2012 Feb 23;119(8):1922-8
pubmed: 22228627
J Virol. 2015 Aug;89(15):7550-66
pubmed: 25972557
Nat Commun. 2020 Jan 24;11(1):510
pubmed: 31980636
Blood Coagul Fibrinolysis. 2018 Apr;29(3):243-251
pubmed: 29517503
Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4719-24
pubmed: 25775592
Proc Natl Acad Sci U S A. 1987 Oct;84(20):7251-5
pubmed: 2444978
Cell Host Microbe. 2020 Mar 11;27(3):317-319
pubmed: 32164842
Int J Mol Sci. 2018 Jun 19;19(6):
pubmed: 29921749
Annu Rev Nutr. 2018 Aug 21;38:431-458
pubmed: 29852086
J Infect Dis. 2015 Oct 1;212 Suppl 2:S109-18
pubmed: 25838270
PLoS One. 2018 May 17;13(5):e0196921
pubmed: 29771935
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
BMC Infect Dis. 2009 Sep 28;9:159
pubmed: 19785757
Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2696-701
pubmed: 26903655
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
N Engl J Med. 1999 Feb 11;340(6):448-54
pubmed: 9971870
J Clin Virol. 2015 Mar;64:111-9
pubmed: 25660265
Nat Rev Immunol. 2021 Jun;21(6):337-339
pubmed: 33850327
Ann N Y Acad Sci. 1982;389:39-48
pubmed: 7046585
Science. 2014 Nov 21;346(6212):987-91
pubmed: 25359852
Cochrane Database Syst Rev. 2016 Mar 11;3:CD011033
pubmed: 26967103
PLoS Negl Trop Dis. 2019 Oct 31;13(10):e0007733
pubmed: 31671094
J Immunol. 2015 Jun 15;194(12):6082-9
pubmed: 25964487
Biol Chem. 2015 Nov;396(11):1181-97
pubmed: 26040008
Viruses. 2015 Jun 25;7(7):3420-42
pubmed: 26120867
J Clin Invest. 1987 Jun;79(6):1635-41
pubmed: 3584463
Lancet. 2020 Mar 7;395(10226):773
pubmed: 32145780
PLoS Pathog. 2012;8(10):e1002877
pubmed: 23055920
J Interferon Cytokine Res. 2019 Jul;39(7):383-392
pubmed: 30897023
Virology. 2013 Nov;446(1-2):230-7
pubmed: 24074586
EMBO Mol Med. 2014 Dec 30;7(1):17-23
pubmed: 25550396
Vector Borne Zoonotic Dis. 2009 Dec;9(6):723-8
pubmed: 19323614
Nat Commun. 2017 Feb 13;8:14446
pubmed: 28194016
J Infect Dis. 2017 Jan 15;215(2):287-292
pubmed: 27799354
Carcinogenesis. 2010 Oct;31(10):1863-72
pubmed: 20427344
Science. 2011 Jun 10;332(6035):1284-8
pubmed: 21566158
Curr Biol. 2011 Jul 26;21(14):R548-50
pubmed: 21783034
Int J Clin Exp Med. 2015 Jan 15;8(1):1173-7
pubmed: 25785110
Sci Rep. 2017 Aug 18;7(1):8763
pubmed: 28821722
J Infect Dis. 1999 Feb;179 Suppl 1:S177-87
pubmed: 9988182
Genome Biol. 2017 Jan 19;18(1):4
pubmed: 28100256
Nat Immunol. 2019 Sep;20(9):1097-1099
pubmed: 31384059
TH Open. 2020 Jun 26;4(2):e138-e144
pubmed: 32607467
Cell Host Microbe. 2018 Mar 14;23(3):297-301.e4
pubmed: 29478775
Curr Biol. 2021 Jan 25;31(2):257-270.e5
pubmed: 33157026
J Gen Virol. 1995 Feb;76 ( Pt 2):393-9
pubmed: 7844558
PLoS Pathog. 2009 Jul;5(7):e1000536
pubmed: 19649327
J Immunol Res. 2018 Jan 14;2018:8917804
pubmed: 29507865
Mediators Inflamm. 2017;2017:9029327
pubmed: 29386753
Am J Pathol. 2003 Dec;163(6):2371-82
pubmed: 14633609
Cytokine. 2017 Oct;98:97-106
pubmed: 28094206
Viruses. 2019 Mar 02;11(3):
pubmed: 30832364
J Infect Dis. 2014 Aug 15;210(4):558-66
pubmed: 24526742
Nat Rev Immunol. 2002 May;2(5):309-22
pubmed: 12033737
Front Pharmacol. 2014 Feb 17;5:19
pubmed: 24596558
Eur J Immunol. 2016 Jan;46(1):13-21
pubmed: 26643360
Cell. 2018 May 17;173(5):1098-1110.e18
pubmed: 29706541
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
Viruses. 2016 Jan 22;8(2):
pubmed: 26805873
Nature. 2020 Jul;583(7817):578-584
pubmed: 32699395
J Virol. 2017 Mar 29;91(8):
pubmed: 28122983
mBio. 2017 Apr 25;8(2):
pubmed: 28442605
Inflammation. 2013 Aug;36(4):921-31
pubmed: 23504259
Nature. 2021 Jan;589(7842):363-370
pubmed: 33473223
Semin Nucl Med. 1989 Apr;19(2):79-88
pubmed: 2652313
N Engl J Med. 2021 Jan 7;384(1):20-30
pubmed: 33332779
Int J Infect Dis. 2020 Oct;99:233-242
pubmed: 32758690
Arthritis Rheum. 2003 Jun;48(6):1475-7
pubmed: 12794811
Elife. 2016 Jul 29;5:
pubmed: 27472900
Emerg Infect Dis. 2013 Feb;19(2):270-3
pubmed: 23343532
Nat Rev Immunol. 2009 Sep;9(9):609-17
pubmed: 19704417

Auteurs

Anitha D Jayaprakash (AD)

Girihlet Inc., Oakland, CA 94609, USA.

Adam J Ronk (AJ)

Department of Pathology, the University Texas Medical Branch, Galveston, TX 77555, USA.
Galveston National Laboratory, the University of Texas Medical Branch, Galveston, TX 77555, USA.

Abhishek N Prasad (AN)

Department of Pathology, the University Texas Medical Branch, Galveston, TX 77555, USA.
Galveston National Laboratory, the University of Texas Medical Branch, Galveston, TX 77555, USA.

Michael F Covington (MF)

Amaryllis Nucleics, Oakland, CA 94609, USA.

Kathryn R Stein (KR)

Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Toni M Schwarz (TM)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Saboor Hekmaty (S)

Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Karla A Fenton (KA)

Galveston National Laboratory, the University of Texas Medical Branch, Galveston, TX 77555, USA.
Department Microbiology & Immunology, the University of Texas Medical Branch, Galveston, TX 77555, USA.

Thomas W Geisbert (TW)

Galveston National Laboratory, the University of Texas Medical Branch, Galveston, TX 77555, USA.
Department Microbiology & Immunology, the University of Texas Medical Branch, Galveston, TX 77555, USA.

Christopher F Basler (CF)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Alexander Bukreyev (A)

Department of Pathology, the University Texas Medical Branch, Galveston, TX 77555, USA.
Galveston National Laboratory, the University of Texas Medical Branch, Galveston, TX 77555, USA.
Department Microbiology & Immunology, the University of Texas Medical Branch, Galveston, TX 77555, USA.

Ravi Sachidanandam (R)

Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH